Francois Nader

Recent appearances

• 

  The Major Falsehood We Believe as Leaders with Dr. Francois Nader

  October 23, 2022 · 📺 Brilliance Within Coaching

  Francois Nader is Chairman of the Board at Acceleron Pharma, Talaris Therapeutics and Benevolent AI. He’s also Board Director at Moderna, and Senior advisor at Blackstone Life Sciences. I was excited to host Dr. Nader in my series, Conversations Life Science Leaders Aren’t Having, because he has a deep passion to share his wisdom and pour into new CEOs. In fact, Dr. Nader almost exclusively supports CEOs who have just taken on their first CEO role. Additionally, from the first time I spoke with Dr. Nader I knew he was not looking to prove anything through our conversation. This quality alway…

  Watch on YouTube ↗

• 

  Episode 3: The Biopharma Exit Strategy With Dr. Francois Nader

  August 12, 2020 · 📺 Life Science Connect

  Every new, emerging biopharma company shares a common goal: creating value for its employees, its board, its investors, and ultimately, patients. Along the way, that value creating might get a boost from an IPO, a merger, an acquisition, or steady growth as a private entity. On this episode of The Business Of Biotech, we talk with Dr. Francois Nader—a man who's orchestrated several wildly successful biotech exits—about why it's imperative to begin with the end in mind, and how to navigate your options when the time is right. #businessofbiotech #biopharma #biotech #cytiva #acceleronpharma htt…

  Watch on YouTube ↗

• 

  #4 Leadership Chat: Francois Nader - A Few Things - 42 Min

  April 17, 2020 · 📺 James Barrood

  We discussed a number of things including: 1. How to lead in a time of great uncertainty 2. Raising funds and managing teams during a downturn 3. What he's seeing in biotech and biopharma sectors 4. Answers to your questions Francois Nader, MD, is a leading value builder in the biopharma industry. Dr. Nader currently serves as chairman of Acceleron Pharma (XLRN), Prevail Therapeutics (PRVL) and Talaris Therapeutics; and board director of Alexion Pharmaceuticals (ALXN) and Moderna (MRNA). Previously, Dr. Nader was President, Chief Executive Officer and Executive Director of NPS Pharma from…

  Watch on YouTube ↗

• 

  Exploring the Future Frontiers of Human Health, with Francois Nader | Big Think.

  February 10, 2015 · 📺 Big Think

  Exploring the Future Frontiers of Human Health, Watch the newest video from Big Think: https://bigth.ink/NewVideo Join Big Think Edge for exclusive videos: https://bigth.ink/Edge ---------------------------------------------------------------------------------- The President & CEO of NPS Pharmaceuticals predicts tremendous growth for the pharmaceutical industry in the coming years as new cures and treatments are developed. He also speaks about the broad scope of pharmaceutical research. The coming decades will see advances in treating minor issues such as the common cold, as well as broad st…

  Watch on YouTube ↗

• 

  Nader Says NPS's Treatments Address `True Medical Need'

  March 23, 2012 · 📺 Bloomberg Originals

  Jan. 10 (Bloomberg) -- Francois Nader, chief executive officer of NPS Pharmaceuticals Inc., talks about his company's products and business strategy. Nader speaks with Shannon Pettypiece at the JPMorgan Healthcare Conference in San Francisco on Bloomberg Television's "Street Smart." (Source: Bloomberg)

  Watch on YouTube ↗